BRIEF published on 02/12/2026 at 18:03, 7 months 11 days ago Résultats annuels 2025 de TF1 : Résilience et stratégie digitale Performance Financière Stratégie Digitale Publicité TF1 Résultats 2025 Studio TF1
REGULATED PRESS RELEASE published on 02/12/2026 at 17:58, 7 months 11 days ago TF1 group 2025 full-year results TF1 group reports resilient performance with 2025 revenue of €2,297 million, digital growth, and proposed €0.63 per share dividend increase. Studio TF1 revenue up 9.2% with JPG contribution Revenue TF1 Group Dividend Digital Growth Studio TF1
REGULATED PRESS RELEASE published on 02/12/2026 at 17:58, 7 months 11 days ago Résultats annuels 2025 du groupe TF1 Résultats annuels 2025 du groupe TF1 : chiffre d'affaires en baisse de 2,5%, forte croissance publicitaire, excédent financier net à 515 M€. Dividende en hausse de 5% Chiffre D'affaires TF1 Résultats Annuels Dividende Excédent Financier
BRIEF published on 02/02/2026 at 18:28, 7 months 21 days ago TF1 Reports Shares and Voting Rights for January 2026 Voting Rights TF1 Shares Disclosure AMF Regulation
BRIEF published on 02/02/2026 at 18:28, 7 months 21 days ago Publication mensuelle des actions et droits de vote de TF1 TF1 Droits De Vote Actions AMF Janvier 2026
REGULATED PRESS RELEASE published on 02/02/2026 at 18:23, 7 months 21 days ago Monthly disclosure of the total number of shares and voting rights - January 2026 TF1 discloses total shares and voting rights for January 31, 2026, as per AMF General Regulation. Theoretical voting rights 211,284,237, Exercisable voting rights 210,367,171 Voting Rights AMF General Regulation TF1 Shares Disclosure
REGULATED PRESS RELEASE published on 02/02/2026 at 18:23, 7 months 21 days ago TF1 - Déclaration mensuelle des actions et droits de vote - Janvier 2026 Publication mensuelle du nombre d'actions et de droits de vote de TF1 selon l'article 223-16 du Règlement général de l'AMF TF1 Droits De Vote Actions AMF Règlement Général
BRIEF published on 01/07/2026 at 18:07, 8 months 16 days ago TF1 Reports Liquidity Contract Update for H2 2025 Liquidity Contract NATIXIS ODDO BHF Share Trading AMF Decision TF1 Financials
BRIEF published on 01/07/2026 at 18:07, 8 months 16 days ago Bilan Semestriel du Contrat de Liquidité de TF1 pour le Second Semestre 2025 NATIXIS ODDO BHF Contrat De Liquidité TF1 AMF Transactions Boursières
REGULATED PRESS RELEASE published on 01/07/2026 at 18:02, 8 months 16 days ago Half-year liquidity contract statement for TF1 - H2 2025 TF1's half-year liquidity contract statement with details on shares, euros, and trading volumes. Implementation in line with AMF Decision n°2021-01 Liquidity Contract TF1 Shares AMF Decision Trading Volumes
Published on 09/23/2026 at 22:00, 9 hours 32 minutes ago Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 13 hours 7 minutes ago Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 15 hours 50 minutes ago Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 17 hours 1 minute ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 17 hours 2 minutes ago Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/24/2026 at 07:15, 17 minutes ago EQS-Adhoc: Shelly Group SE enters into Investment Agreement with Schneider Electric SE
Published on 09/24/2026 at 07:00, 32 minutes ago flatexDEGIRO sets new cost benchmark for Germany’s Retirement Savings Account (Altersvorsorgedepot)
Published on 09/24/2026 at 07:00, 32 minutes ago Europe’s small & mid caps: Opportunities remain intact in a new investment era
Published on 09/24/2026 at 07:00, 32 minutes ago bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies
Published on 09/24/2026 at 07:00, 32 minutes ago bioMérieux lance SPINCHIP® hs-cTnl, une innovation majeure pour le dosage hypersensible de la troponine I cardiaque et l’accélération de la prise en charge des urgences cardiaques
Published on 09/23/2026 at 19:46, 11 hours 45 minutes ago SFPI GROUP: publication des résultats semestriels 2026
Published on 09/23/2026 at 19:14, 12 hours 17 minutes ago Robust performance from Investments and continued execution of the strategy
